-
Duplex sequencing of selected breast cancer patients
Dataset
EGAD50000000769
-
WES of breast cancer patients and controls
Dataset
EGAD50000000770
-
Cancer cell and tumor microenvironment biomarkers associated with disease-free survival with adjuvant nivolumab in the phase 3 CheckMate 274 trial
Study
EGAS50000000560
-
ROBUST (NCT02285062)
Study
EGAS50000000333
-
HiDEF-seq single-molecule sequencing of single-strand mismatches and damage
Study
EGAS50000000318
-
WES data from 438 tumor/germline samples with non muscle invasive bladder cancer
Dataset
EGAD50000000730
-
Long Read sequencing data from 4 tumor/germline samples with non muscle invasive bladder cancer
Dataset
EGAD50000000731
-
sWGS data from 362 tumor with non muscle invasive bladder cancer and 30 blood samples (15 males and 15 females)
Dataset
EGAD50000000732
-
RnaSeq data from 414 tumor samples with non muscle invasive bladder cancer
Dataset
EGAD50000000733
-
PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis
Dac
EGAC00001003503